Laryngeal Mask Co. Ltd. v. Ambu

618 F.3d 1367, 96 U.S.P.Q. 2d (BNA) 1757, 2010 U.S. App. LEXIS 19658, 2010 WL 3633180
CourtCourt of Appeals for the Federal Circuit
DecidedSeptember 21, 2010
Docket2010-1028, 2010-1062
StatusPublished
Cited by26 cases

This text of 618 F.3d 1367 (Laryngeal Mask Co. Ltd. v. Ambu) is published on Counsel Stack Legal Research, covering Court of Appeals for the Federal Circuit primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Laryngeal Mask Co. Ltd. v. Ambu, 618 F.3d 1367, 96 U.S.P.Q. 2d (BNA) 1757, 2010 U.S. App. LEXIS 19658, 2010 WL 3633180 (Fed. Cir. 2010).

Opinion

MOORE, Circuit Judge.

The Laryngeal Mask Company Ltd. and LMA North America, Inc. (collectively, LMA) appeal the district court’s summary judgment that the Aura40TM; AuraOnce-™, and AuraStraight™ products made by Ambu A/S, Ambu Inc., and Ambu Ltd. (collectively, Ambu) did not infringe the asserted claims of U.S. Patent No. 7,156,-100 ('100 patent) and that all claims were invalid for lack of written description under 35 U.S.C. § 112. We conclude that the district court erred in its construction of the claim term “backplate.” Because its summary judgment of no infringement was predicated on this erroneous claim construction, we vacate. We further conclude *1369 that LMA has raised a genuine issue of material fact precluding summary judgment on the issue of -written description, and we therefore vacate the court’s judgment of invalidity and remand for further proceedings.

Background

The TOO patent concerns laryngeal mask airway devices, which are artificial airway devices used to deliver anesthetic gases during surgery and to establish unobstructed airways in patients in emergency situations. TOO patent col.l 11.10-13. As shown below, these devices include an airway tube [47] attached to a baekplate [52], which is surrounded by an inflatable cuff [55]. The device is inserted into the patient’s mouth and throat until the far (distal) end of the cuff meets the opening of the esophagus [37], The cuff is inserted in a deflated state. Once in place, the cuff is inflated using a cuff airway tube [62], forming a seal around the patient’s laryngeal inlet and preventing gases from entering the esophagus. Anesthetic gas or air can then flow into the patient’s laryngeal inlet via the airway tube [47].

[[Image here]]

TOO patent, fig. 2.

Laryngeal mask airway devices were pioneered in the 1980s by Dr. Archibald Brain, the inventor listed on the TOO patent. According to the TOO patent, one problem with prior art laryngeal mask airway devices is that during insertion, the leading edge of the deflated cuff will occasionally fold over on itself, allowing the more rigid distal end of the mask to catch the inside of the patient’s throat. Id. col.l 11.31-35. This can be unpleasant for the patient and may prevent the cuff from making a full seal around the patient’s laryngeal inlet. Id. col.l 11.46-40. The invention of the TOO patent seeks to minimize the risk that the deflated cuff will fold over on itself by adding a “reinforcing rib which serves to stiffen the leading end of the LMA-device during the course of the procedure for its insertion.” Id. col.l 11.47-54.

LMA filed suit against Ambu, asserting that certain of Ambu’s laryngeal mask airway devices infringed claims 1 to 6 of the TOO patent. Ambu’s accused products include its Aura40™, AuraOnceTM, and AuraStraightTM laryngeal mask airway devices. The district court construed the disputed terms of the TOO patent. Relevant to this appeal, the court construed the claim term “baekplate” as “the relatively rigid mask structure surrounded by the cuff and including a tube joint.” The Laryngeal Mask Co. v. Ambu A/S, Civ. No. 07-CV-1988, D.I. 171, 7 (S.D.Cal. Mar. 17, 2009) (Claim Construction Order). The tube joint is the connection between the mask and the airway tube. See, e.g., TOO patent figs. 2-3. The district court concluded that Ambu’s accused devices 1 do not have a tube joint because the mask structure and the airway tube are integrally molded — they are one continuous piece rather than two pieces joined together by a joint. Because the accused products *1370 lacked a tube joint the district court concluded they lacked a backplate. The Laryngeal Mask Co. v. Ambu A/S, Civ. No. 07-CV-1988, D.I. 224, 5 (S.D. Cal. June 25, 2009) (Noninfringement Order). Therefore, the court granted summary judgment that Ambu’s Aura40TM; AuraOnce™, and AuraStraightTM products do not literally infringe claims 1 to 6 of the '100 patent. Id. at 6. The court also granted summary judgment of noninfringement under the doctrine of equivalents, concluding that it would vitiate the backplate limitation to equate a backplate that includes a tube joint to a backplate molded directly to an airway tube. Id. at 8.

The district court further granted Ambu’s motion for summary judgment of invalidity for lack of written description. The Laryngeal Mask Co. v. Ambu A/S, Civ. No. 07-CV-1988, D.I. 476 (S.D.Cal. Sept, 25, 2009) (Invalidity Order). The court determined that the specification failed to adequately describe a mask having “at least a portion of the posterior portion of a wall of the cuff in the distal region being thicker and stiffer than other portions of the cuff,” as required by claim 1. Id. at 4-6. The court thus concluded that claim 1 and its dependent claims were invalid under 35 U.S.C. § 112, ¶ 1. Invalidity Order at 7.

LMA appeals, challenging the court’s claim construction and judgments of noninfringement and invalidity. We have jurisdiction under 28 U.S.C. § 1295(a)(1).

Discussion

This court reviews a grant of summary judgment de novo. Immunocept, L.L.C. v. Fulbright & Jaworski, L.L.P., 504 F.3d 1281, 1286 (Fed.Cir.2007). “Summary judgment is appropriate when there is no genuine issue as to any material fact and the moving party is entitled to judgment as a matter of law.” Id.

I. Claim Construction

We review claim construction de novo. Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448, 1455-56 (Fed.Cir.1998) (en banc). The words of a claim are generally given their ordinary and customary meaning as understood by a person of ordinary skill in the art in question at the time of the invention when read in the context of the specification and prosecution history. See Phillips v. AWH Corp., 415 F.3d 1303, 1313 (Fed.Cir.2005) (en banc).

Claims 1 to 6 are at issue. Claims 2 to 6 all depend from claim 1, which reads:

1. A laryngeal-mask airway device comprising:
a backplate defining a passage;
an inflatable cuff, the cuff defining a distal region and a central opening at least when inflated, the cuff being attached to the backplate,

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Terracino v. Trimaco, Inc.
E.D. North Carolina, 2024
Ross-Hime Designs, Inc. v. United States
126 Fed. Cl. 299 (Federal Claims, 2016)
Intellicheck Mobilisa, Inc. v. Wizz Systems, LLC
173 F. Supp. 3d 1085 (W.D. Washington, 2016)
Vasudevan Software, Inc. v. Tibco Software, Inc.
782 F.3d 671 (Federal Circuit, 2015)
Plantronics, Inc. v. Aliph, Inc.
724 F.3d 1343 (Federal Circuit, 2013)
Accent Packaging, Inc. v. Leggett & Platt, Inc.
707 F.3d 1318 (Federal Circuit, 2013)
Jang v. Boston Scientific Corp.
493 F. App'x 70 (Federal Circuit, 2012)
Sanofi-Aventis Deutschland & GMBH v. Genentech, Inc.
473 F. App'x 885 (Federal Circuit, 2012)

Cite This Page — Counsel Stack

Bluebook (online)
618 F.3d 1367, 96 U.S.P.Q. 2d (BNA) 1757, 2010 U.S. App. LEXIS 19658, 2010 WL 3633180, Counsel Stack Legal Research, https://law.counselstack.com/opinion/laryngeal-mask-co-ltd-v-ambu-cafc-2010.